PatientsLikeMe ™

MS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


What is Skelaxin? Skelaxin is a brand name for the drug metaxalone, a muscle relaxant used in the treatment of pain from sprains, strains, and other musculoskeletal conditions. Skelaxin is a brand name owned by King Pharmaceuticals. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.

King Pharmaceuticals's Skelaxin site


Reasons Taken

34 patients in the community are taking or have taken Skelaxin.

Reason # Patients Percentage of patients
Stiffness/spasticity 20 58%
Other 4 11%
Pain 4 11%
Headache 2 5%
Lower back pain 2 5%
disease-related symptoms 1 2%

Dosages

Based on the patients currently taking Skelaxin.

  0 mg none 25 mg day 100 mg day 400 mg day 800 mg day 1200 mg day 1600 mg day 2400 mg day 3200 mg day
  6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 9 Number of Patients: 9 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2  

Duration

How long current patients have been taking Skelaxin or how long patients were taking Skelaxin before stopping.

Currently taking Skelaxin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
3
7
2
1
4

Stopped taking Skelaxin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
0
3
0
2
Why Patients Stopped Taking Skelaxin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3 33% Did not seem to work: 33%
Other 3 33% Other: 33%
Expense 1 11% Expense: 11%
Side effects too severe 1 11% Side effects too severe: 11%
Course of treatment ended 1 11% Course of treatment ended: 11%


Back to top